BBIO EBITDA Growth
Bridgebio Pharma Inc · EBITDA Growth
BBIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported5.02%period ending
BBIO TTM EBITDA YoY % (-67.45% → 5.02%)
Year-over-year change
High-resolution chart · PNG
BBIO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 5.0231% | |
| -10.9594% | |
| -43.3135% | |
| -93.3671% | |
| -74.8202% | |
| -21.1457% | |
| 22.7491% | |
| 34.6431% | |
| 25.9406% | |
| -34.2639% | |
| -42.2765% | |
| -29.4023% | |
| -11.6797% | |
| 38.5466% | |
| 25.5492% | |
| 20.6374% | |
| 9.3568% | |
| -4.7202% | |
| -14.5511% | |
| -23.3281% | |
| -35.4964% | |
| -69.6281% | |
| -66.9898% | |
| -71.7969% | |
| -58.2818% | |
| -61.872% | |
| -67.4509% |